Alvotech (ALVO) News Today $11.58 +0.44 (+3.95%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$11.67 +0.09 (+0.81%) As of 05/30/2025 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALVO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Alvotech (NASDAQ:ALVO) Shares Up 5% - Here's WhyAlvotech (NASDAQ:ALVO) Stock Price Up 5% - Here's WhyMay 31 at 2:09 PM | marketbeat.comAlvotech and Advanz to commercialise biosimilars in EuropeMay 30 at 5:28 PM | finance.yahoo.comAlvotech (NASDAQ:ALVO) Shares Gap Up - Still a Buy?Alvotech (NASDAQ:ALVO) Shares Gap Up - Time to Buy?May 28 at 12:03 PM | marketbeat.comAlvotech and Advanz Pharma Expand Biosimilar Partnership in EuropeMay 28 at 11:19 AM | tipranks.comAlvotech and Advanz Pharma add three more biosimilars to collaborationMay 28 at 7:51 AM | seekingalpha.comAlvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in EuropeMay 28 at 6:15 AM | globenewswire.comAlvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in EuropeMay 28 at 6:15 AM | globenewswire.comAlvotech Annual General Meeting to be held June 25, 2025 | ALVO Stock NewsMay 26, 2025 | gurufocus.comAlvotech Annual General Meeting to be held June 25, 2025May 26, 2025 | globenewswire.comTransactions of Managers and Closely Associated PersonsMay 23, 2025 | globenewswire.comAlvotech (NASDAQ:ALVO) Shares Sold by Sculptor Capital LPSculptor Capital LP lessened its stake in Alvotech (NASDAQ:ALVO - Free Report) by 35.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 606,170 shares of the company's stock after selling 338,928 shares during theMay 19, 2025 | marketbeat.comTrading in Alvotech’s Shares on Nasdaq Stockholm Commences TodayMay 19, 2025 | finance.yahoo.comAlvotech Announces Successful Listing of Swedish Depository Receipts on Nasdaq StockholmMay 19, 2025 | quiverquant.comAlvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq StockholmMay 19, 2025 | globenewswire.comTrading in Alvotech's Shares on Nasdaq Stockholm Commences TodayMay 19, 2025 | globenewswire.comPointState Capital LP Has $16.42 Million Stock Holdings in Alvotech (NASDAQ:ALVO)PointState Capital LP raised its holdings in shares of Alvotech (NASDAQ:ALVO - Free Report) by 64.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,241,379 shares of the company's stock after buyingMay 17, 2025 | marketbeat.comAlvotech Announces the Outcome of the Offering in Connection with the Company’s Listing on Nasdaq StockholmMay 16, 2025 | finance.yahoo.comAlvotech Announces the Outcome of the Offering in Connection with the Company's Listing on ...May 16, 2025 | gurufocus.comAlvotech Announces the Outcome of the Offering in Connection with the Company's Listing on Nasdaq StockholmMay 16, 2025 | globenewswire.comTransactions of Managers and Closely Associated PersonsMay 16, 2025 | globenewswire.comThere May Be Underlying Issues With The Quality Of Alvotech's (NASDAQ:ALVO) EarningsMay 15, 2025 | finance.yahoo.comAlvotech (ALVO) Expected to Announce Quarterly Earnings on TuesdayAlvotech (NASDAQ:ALVO) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 20. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-20-alvotech-stock/)May 15, 2025 | marketbeat.comTransactions of Managers and Closely Associated PersonsMay 13, 2025 | globenewswire.comAlvotech 2025 Q1 - Results - Earnings Call PresentationMay 11, 2025 | seekingalpha.comAlvotech (ALVO) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comBest Drug for Acute Severe UC? Genotypes and Liver Fibrosis; Boosting CRC ScreeningMay 9, 2025 | msn.comIs Alvotech (ALVO) The Best Stock That Will Bounce Back?May 9, 2025 | msn.comAlvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, NevadaMay 9, 2025 | finance.yahoo.comAlvotech CEO Acquires Significant Shareholding, Strengthening Market ConfidenceMay 9, 2025 | tipranks.comTransactions of Managers and Closely Associated PersonsMay 9, 2025 | globenewswire.comXbrane Biopharma AB: Xbrane Biopharma releases Interim Report January-March 2025May 8, 2025 | finanznachrichten.deAlvotech Publishes Prospectus in Connection with its Listing on Nasdaq Stockholm | ALVO Stock NewsMay 8, 2025 | gurufocus.comAlvotech Publishes Prospectus in Connection with its Listing on Nasdaq StockholmMay 8, 2025 | globenewswire.comAlvotech Reports Results for the First Quarter of 2025 and Provides Business UpdateMay 7, 2025 | globenewswire.comAlvotech Reports Results for the First Quarter of 2025 and Provides Business UpdateMay 7, 2025 | globenewswire.comPotential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025May 7, 2025 | finance.yahoo.comAlvotech sees minimal impact on 2025 product revenues from tariffsMay 7, 2025 | seekingalpha.comAlvotech Anticipates Minimal Impact from Potential U.S. Tariffs on Imported Pharmaceuticals in 2025May 7, 2025 | quiverquant.comAlvotech Addresses Potential Impact of U.S. Tariffs on Imported PharmaceuticalsMay 7, 2025 | quiverquant.comPotential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech's Product Revenues in 2025May 7, 2025 | globenewswire.comPotential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech's Product Revenues in 2025May 7, 2025 | globenewswire.comFDA approves Selarsdi injection as interchangeable with StelaraMay 6, 2025 | finance.yahoo.comWhy Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?May 5, 2025 | benzinga.comAlvotech’s SELARSDI Gains FDA Approval for Interchangeability with StelaraMay 5, 2025 | tipranks.comFDA Approves Alvotech's SELARSDI as Interchangeable with Stelara | ALVO stock newsMay 5, 2025 | gurufocus.comTeva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)May 5, 2025 | financialpost.comTeva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)May 5, 2025 | globenewswire.comAlvotech (NASDAQ:ALVO) Short Interest UpdateAlvotech (NASDAQ:ALVO - Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 794,500 shares, an increase of 23.7% from the March 31st total of 642,500 shares. Based on an average daily volume of 149,700 shares, the days-to-cover ratio is currently 5.3 days. Currently, 0.7% of the shares of the stock are sold short.May 4, 2025 | marketbeat.comAlvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDTMay 2, 2025 | globenewswire.comAlvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT (14:00 CET)May 2, 2025 | globenewswire.com Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Email Address ALVO Media Mentions By Week ALVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALVO News Sentiment▼0.670.88▲Average Medical News Sentiment ALVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALVO Articles This Week▼114▲ALVO Articles Average Week Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RDY News Today MRNA News Today ASND News Today VTRS News Today QGEN News Today ROIV News Today RVMD News Today BPMC News Today BBIO News Today ELAN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALVO) was last updated on 5/31/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALVO Stock Free ALVO Stock Alerts